Parabilis Medicines Statistics
NASDAQ: PBLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
27.44-0.185 (-0.67%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Parabilis Medicines by the numbers
Parabilis Medicines has a market capitalization of $3.44 billion based on 123.68M shares outstanding. With trailing EPS of $-3.62, Parabilis Medicines is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.0% below its 50-day average and 13.6% below its 200-day average.
Average daily trading volume is 975.55K shares, or about $26.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PBLS valuation vs. peer median
| Metric | PBLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.44B | $3.41B | +1% |
| Avg. volume | 975.55K | 1.92M | -49% |
Peer median across 8 companies: IRON, ELVN, VRDN, AMLX, ARQT, XENE, OGN, ABCL.
Valuation
- Market cap
- $3.44B
- EPS (TTM)
- $-3.62
- Shares outstanding
- 123.68M
Price and trading
- Previous close
- 27.63
- Open
- 27.09
- Day range
- 26.50 – 28.52
- 52-week range
- 22.66 – 42.49
- Beta
- —
- Volume
- 1.25M
- Average volume
- 975.55K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 3.44B
- Forward Pe
- -11.69
- Eps
- -3.62
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.49
- Week52 Low
- 22.66
- Avg Volume
- 975.55K
- Shares Outstanding
- 123.68M
- Ma50
- 29.83
- Ma200
- 31.75
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -35.42%
- Pct From52w Low
- 21.09%